380 related articles for article (PubMed ID: 14724225)
1. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
2. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
[TBL] [Abstract][Full Text] [Related]
3. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.
Bowman ZS; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2005 Dec; 315(3):980-6. PubMed ID: 16099929
[TBL] [Abstract][Full Text] [Related]
4. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
Bolchoz LJ; Morrow JD; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2002 Oct; 303(1):141-8. PubMed ID: 12235244
[TBL] [Abstract][Full Text] [Related]
5. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.
Bowman ZS; Morrow JD; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764
[TBL] [Abstract][Full Text] [Related]
6. Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Gelasco AK; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2002 Dec; 303(3):1121-9. PubMed ID: 12438535
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
8. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Grossman S; Budinsky R; Jollow D
J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
[TBL] [Abstract][Full Text] [Related]
9. Role of oxidant stress in lawsone-induced hemolytic anemia.
McMillan DC; Sarvate SD; Oatis JE; Jollow DJ
Toxicol Sci; 2004 Dec; 82(2):647-55. PubMed ID: 15456924
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.
Allahyari R; Strother A; Fraser IM; Verbiscar AJ
J Med Chem; 1984 Mar; 27(3):407-10. PubMed ID: 6699888
[TBL] [Abstract][Full Text] [Related]
11. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes.
McMillan DC; Simson JV; Budinsky RA; Jollow DJ
J Pharmacol Exp Ther; 1995 Jul; 274(1):540-7. PubMed ID: 7616443
[TBL] [Abstract][Full Text] [Related]
12. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
[TBL] [Abstract][Full Text] [Related]
13. The hemotoxicity of para-substituted aniline analogs in dog and rat erythrocytes: a species comparison.
Purnell ET; Singh H
Ethn Dis; 2005; 15(4 Suppl 5):S5-81-7. PubMed ID: 16315385
[TBL] [Abstract][Full Text] [Related]
14. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo.
Vásquez-Vivar J; Augusto O
Biochem Pharmacol; 1994 Jan; 47(2):309-16. PubMed ID: 8304975
[TBL] [Abstract][Full Text] [Related]
15. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
Wang YM; Patterson JH; Van Eys J
J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
[TBL] [Abstract][Full Text] [Related]
16. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.
Jensen CB; Jollow DJ
Toxicol Appl Pharmacol; 1991 Oct; 111(1):1-12. PubMed ID: 1949026
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
Fletcher KA; Barton PF; Kelly JA
Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
[TBL] [Abstract][Full Text] [Related]
18. Dapsone-induced hemolytic anemia.
Jollow DJ; Bradshaw TP; McMillan DC
Drug Metab Rev; 1995; 27(1-2):107-24. PubMed ID: 7641572
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.
Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS
Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898
[TBL] [Abstract][Full Text] [Related]
20. OXIDATIVE HEMOLYSIS AND ERYTHROCYTE METABOLISM IN HEREDITARY ACATALASIA.
JACOB HS; INGBAR SH; JANDL JH
J Clin Invest; 1965 Jul; 44(7):1187-99. PubMed ID: 14328395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
